Apply to Graduate School | Library | Jobs & Volunteers | Visitor Information | Department Index | News      
Section of Molecular Medicine at Wake forest university School of Medicine

Allen W. Tsang, PhD

Assistant Professor, Section on Molecular Medicine

Email: atsang@wfubmc.edu

Education:
B.S.,   1994, University of Wisconsin – Madison
Ph.D., 1998, University of Wisconsin – Madison

Professional Training:
2003 - 2006   Assistant Research Professor

University of Massachusetts, Biotechnology Center  
Enzymatic Fuel Cells, Biological Nanostructures  
1999 - 2003 Postdoctoral Associate
University of Nebraska, The Redox Biology Center University of Nebraska, Bioinformatics
University of Georgia, Department of Biochemistry

 

The image “file:///C:/Documents%20and%20Settings/atsang/Desktop/Allensearth-1.jpg” cannot be displayed, because it contains errors.

 

 

 

 

 

Research Areas:
Kinetic Modeling of Redox Signaling Networks, Elucidation of PDGF Signaling Cascades in Cancer and Heart Disease, CO Signaling

Current Research:
The overall objectives of our research are: i] investigate the molecular mechanisms that control redox modulated signaling networks and, ii] quantify the effect of oxidation on the timing of signaling events. To understand these fundamental features of cell signaling, we apply novel proteomics methods based on kinetics and mass spectrometry. In this context, we are interested in two major research areas:

(1) Mapping phosphorylation events associated with oxidative and radiation
     damage esponse; the effect of these events on cell cycle regulation.

(2) The effect of carbon monoxide on signaling networks. The potential of carbon
 monoxide (CO) to act as enzyme activity modulator and regulator of
 transcription has only recently been established. However, less is known
 about the effect of CO on signaling pathways. To that end, we will apply mass
 spectrometry based proteomics to uncover dynamic changes in specific
 signaling pathways in response to increased levels of CO.

(3)  Cell signaling networks modeling to achieve a better understanding of the
 events leading to pathological changes in signaling networks.

(4)  Clinical proteomics to identify potential targets for cancer therapies.

(5)  Development of Milliseconds Timescale Kinetics Chips  for Quantitative 
 Monitoring of Enzyme Catalysis by MS

 

HPLC-Chip+no background_150dpi040928_1_Gesamtansicht_explodiert040928_1_Gesamtansicht_clamp_geschlossen

 

Customized Nanokinetics Chip moves into spray position

 

new_camera_spray_image2_0793

 

Publications:

 

Thomas J. Jönsson, Allen W. Tsang, W. Todd Lowther, and Cristina M. Furdui Identification of intact protein thiosulfinate intermediate in the reduction of
cysteine sulfinic acid in peroxiredoxin by human sulfiredoxin
J. Biol. Chem., Jun 2008